Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.77B | 3.91B | 4.17B | 4.12B | 4.04B | Gross Profit |
2.86B | 2.18B | 2.20B | 2.21B | 2.24B | EBIT |
-12.00M | 139.00M | 256.00M | 376.00M | 380.00M | EBITDA |
512.00M | 1.06B | 1.03B | 1.13B | 1.15B | Net Income Common Stockholders |
-39.00M | 54.00M | 30.00M | 155.00M | 229.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
0.00 | 150.00M | 273.00M | 156.00M | 1.27B | Total Assets |
10.45B | 10.75B | 11.12B | 10.34B | 9.68B | Total Debt |
985.00M | 4.03B | 4.18B | 3.75B | 3.48B | Net Debt |
985.00M | 3.88B | 3.90B | 3.59B | 2.21B | Total Liabilities |
5.84B | 6.10B | 6.54B | 5.77B | 5.25B | Stockholders Equity |
4.58B | 4.63B | 4.55B | 4.55B | 4.41B |
Cash Flow | Free Cash Flow | |||
346.00M | 128.00M | -355.00M | -1.24B | 47.00M | Operating Cash Flow |
883.00M | 866.00M | 832.00M | 802.00M | 1.24B | Investing Cash Flow |
-556.00M | -721.00M | -1.18B | -2.04B | -1.16B | Financing Cash Flow |
-347.00M | -274.00M | 456.00M | 142.00M | 926.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $4.66B | 8.16 | 29.05% | 5.98% | -0.15% | 17.96% | |
75 Outperform | $5.08B | 11.31 | 6.76% | 2.65% | 8.78% | -21.85% | |
69 Neutral | $8.00B | 8.95 | 11.19% | 5.41% | -2.34% | 12.31% | |
65 Neutral | $5.48B | ― | -0.85% | ― | -3.48% | -169.60% | |
63 Neutral | $5.13B | 4.42 | 23.27% | ― | -26.74% | ― | |
58 Neutral | $25.04B | 3.23 | -10.53% | 4.39% | 2.30% | -43.13% | |
56 Neutral | $1.43B | 98.96 | 0.80% | 4.70% | -5.87% | -93.49% |
UScellular has introduced its 2025 Annual Incentive Plan, approved by its Chair and CEO on January 13, 2025, which targets motivating its executives by aligning their performance with the company’s business goals. The plan emphasizes company performance, accounting for 80% of the evaluation, based on financial metrics like total service revenues and operating cash flow, while individual performance accounts for the remaining 20%.